Xiaoyan Wang1, Miaohan Qiu1, Jing Qi1, Jing Li1, Heyang Wang1, Yi Li1, Yaling Han1. 1. 1 Graduate school, Dalian Medical University, Dalian 116044, China ; 2 Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang 110016, China.
Abstract
BACKGROUND: Data focused on the ischemic events and bleeding events are still limited. We systematically reviewed the current available literature to investigate whether anemia increase incidence of long-term ischemic events and long-term bleeding events in patients undergoing PCI. METHODS: PubMed and Embase were searched for case-control studies regarding the impact of anemia on long-term outcomes in patients undergoing percutaneous coronary intervention (PCI). The primary outcome was long-term ischemic events and long-term bleeding events. Mantel-Haenszel method with random effects model or fixed effects model was used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Seventeen studies involving 68,528 patients (17,123 anemic patients and 51,405 non-anemic patients) were included. Pooled analysis suggested that anemic patients were at higher risk for long-term composite ischemic events (OR: 1.95, 95% CI, 1.21-3.14, P<0.01, I(2)=84%), long-term reinfarction (0R: 1.63, 95% CI, 1.16-2.28, P<0.01, I(2)=82%) and long-term bleeding events (OR: 2.89, 95% CI, 1.68-4.98, P<0.001, I(2)=89%). Anemia was also associated with long-term mortality (OR: 3.20, 95% CI, 2.72-3.75, P<0.01, I(2)=65%) and major adverse cardiac events (MACE) (OR: 2.06, 95% CI, 1.48-2.86, P<0.01, I(2)=91%). CONCLUSIONS: Anemic patients undergoing PCI are at higher risk for both long-term ischemic events and bleeding events, and also at higher risk for long-term mortality and MACE. There's a need for further clarification and consistency regarding dosage, timing and duration of antithrombotic therapy for the prevention of ischemic events and bleeding events in anemic patients.
BACKGROUND: Data focused on the ischemic events and bleeding events are still limited. We systematically reviewed the current available literature to investigate whether anemia increase incidence of long-term ischemic events and long-term bleeding events in patients undergoing PCI. METHODS: PubMed and Embase were searched for case-control studies regarding the impact of anemia on long-term outcomes in patients undergoing percutaneous coronary intervention (PCI). The primary outcome was long-term ischemic events and long-term bleeding events. Mantel-Haenszel method with random effects model or fixed effects model was used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Seventeen studies involving 68,528 patients (17,123 anemicpatients and 51,405 non-anemicpatients) were included. Pooled analysis suggested that anemicpatients were at higher risk for long-term composite ischemic events (OR: 1.95, 95% CI, 1.21-3.14, P<0.01, I(2)=84%), long-term reinfarction (0R: 1.63, 95% CI, 1.16-2.28, P<0.01, I(2)=82%) and long-term bleeding events (OR: 2.89, 95% CI, 1.68-4.98, P<0.001, I(2)=89%). Anemia was also associated with long-term mortality (OR: 3.20, 95% CI, 2.72-3.75, P<0.01, I(2)=65%) and major adverse cardiac events (MACE) (OR: 2.06, 95% CI, 1.48-2.86, P<0.01, I(2)=91%). CONCLUSIONS:Anemicpatients undergoing PCI are at higher risk for both long-term ischemic events and bleeding events, and also at higher risk for long-term mortality and MACE. There's a need for further clarification and consistency regarding dosage, timing and duration of antithrombotic therapy for the prevention of ischemic events and bleeding events in anemicpatients.
Authors: Sergio Manzano-Fernández; Francisco Marin; Jose A Hurtado Martinez; Francisco Cambronero; Mariano Valdés; Juan Miguel Ruiz-Nodar; Patricio Pérez-Berbel; Gregory Y H Lip Journal: QJM Date: 2008-07-29
Authors: Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; W Robb MacLellan; Jeff Borenstein Journal: J Am Coll Cardiol Date: 2002-06-05 Impact factor: 24.094
Authors: Amir Halkin; Mandeep Singh; Eugenia Nikolsky; Cindy L Grines; James E Tcheng; Eulogio Garcia; David A Cox; Mark Turco; Thomas D Stuckey; Yingo Na; Alexandra J Lansky; Bernard J Gersh; William W O'Neill; Roxana Mehran; Gregg W Stone Journal: J Am Coll Cardiol Date: 2005-05-03 Impact factor: 24.094
Authors: Tomasz Kurek; Radosław Lenarczyk; Jacek Kowalczyk; Andrzej Swiatkowski; Oskar Kowalski; Joanna Stabryła-Deska; Grzegorz Honisz; Andrzej Lekston; Zbigniew Kalarus; Tomasz Kukulski Journal: Am J Cardiol Date: 2010-03-01 Impact factor: 2.778
Authors: Vijay Kunadian; Roxana Mehran; A Michael Lincoff; Frederick Feit; Steven V Manoukian; Martial Hamon; David A Cox; George D Dangas; Gregg W Stone Journal: Am J Cardiol Date: 2014-09-28 Impact factor: 2.778
Authors: Eugenia Nikolsky; Eve D Aymong; Amir Halkin; Cindy L Grines; David A Cox; Eulogio Garcia; Roxana Mehran; James E Tcheng; John J Griffin; Giulio Guagliumi; Thomas Stuckey; Mark Turco; David A Cohen; Manuela Negoita; Alexandra J Lansky; Gregg W Stone Journal: J Am Coll Cardiol Date: 2004-08-04 Impact factor: 24.094
Authors: Pamela N Peterson; David J Magid; Ella E Lyons; Christina L Clarke; Chan Zeng; Ashley Fitzgerald; JoAnn Lindenfeld; Mikhail Kosiborod; David Brand; Frederick A Masoudi Journal: Am Heart J Date: 2010-01 Impact factor: 4.749